Use of 3-Dimensional (3D) Ultrasound Imaging to Guide the Treatment of Abdominal Tumours Using Focal Ablation or Biopsies

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

This study is to assess the addition of 3D ultrasound guidance during standard care ablation or biopsies of liver or kidney tumours. 3D ultrasound only differs from conventional 2D ultrasound in that the ultrasound transducer is mounted on a special assembly that moves the transducer in precise, stepped movements while a succession of 2D images are collected by the computer. Special software written specifically for 3D ultrasound precisely aligns these 2D images into a 3-demensional volume , allowing area in question to be viewed in many different planes. 3D ultrasound is a safe, fast, non-invasive imaging procedure. Ultrasound images will be checked against the pre- and post- procedure CT images to make sure the tumours were completely removed or properly targeted during biopsy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• • Patients who are scheduled for standard care liver or kidney ablation or biopsy

Locations
Other Locations
Canada
Victoria Hospital
RECRUITING
London
Contact Information
Primary
Aaron Fenster
afenster@uwo.ca
5199315777
Time Frame
Start Date: 2020-10-03
Estimated Completion Date: 2027-02
Participants
Target number of participants: 40
Treatments
Patients
Cancer patients who are scheduled to undergo an ablation or biopsy of a liver or kidney tumour
Sponsors
Leads: Western University, Canada

This content was sourced from clinicaltrials.gov